Guggenheim Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.8M Sell
54,858
-6,656
-11% -$2.47M 0.14% 132
2026
Q1
$16.6M Sell
61,514
-16,197
-21% -$4.82M 0.13% 164
2025
Q4
$25.7M Sell
77,711
-1,823
-2% -$618K 0.18% 109
2025
Q3
$27.5M Sell
79,534
-1,744
-2% -$527K 0.2% 101
2025
Q2
$25.4M Sell
81,278
-8,552
-10% -$3.27M 0.2% 101
2025
Q1
$47M Sell
89,830
-6,562
-7% -$3.35M 0.43% 48
2024
Q4
$48.8M Sell
96,392
-2,609
-3% -$1.48M 0.4% 44
2024
Q3
$57.9M Sell
99,001
-1,811
-2% -$1.02M 0.41% 41
2024
Q2
$51.3M Buy
100,812
+4,992
+5% +$2.45M 0.36% 47
2024
Q1
$47.4M Buy
95,820
+12,890
+16% +$6.55M 0.33% 51
2023
Q4
$43.7M Buy
82,930
+3,331
+4% +$1.78M 0.33% 51
2023
Q3
$40.1M Buy
79,599
+6,135
+8% +$3.02M 0.35% 53
2023
Q2
$35.3M Buy
73,464
+1,484
+2% +$726K 0.28% 64
2023
Q1
$34M Sell
71,980
-2,239
-3% -$1.08M 0.29% 60
2022
Q4
$39.3M Buy
74,219
+1,326
+2% +$702K 0.35% 52
2022
Q3
$36.8M Sell
72,893
-13,652
-16% -$7.18M 0.34% 55
2022
Q2
$44.5M Sell
86,545
-24,668
-22% -$12.4M 0.35% 42
2022
Q1
$56.7M Sell
111,213
-29,875
-21% -$14.4M 0.34% 41
2021
Q4
$70.8M Sell
141,088
-7,248
-5% -$3.28M 0.37% 38
2021
Q3
$58M Sell
148,336
-19,951
-12% -$8.26M 0.35% 44
2021
Q2
$67.4M Sell
168,287
-1,407
-0.8% -$561K 0.4% 28
2021
Q1
$63.1M Sell
169,694
-7,200
-4% -$2.49M 0.41% 27
2020
Q4
$62M Buy
176,894
+12,460
+8% +$4.18M 0.39% 29
2020
Q3
$51.3M Sell
164,434
-4,374
-3% -$1.34M 0.37% 34
2020
Q2
$49.8M Buy
168,808
+24,796
+17% +$7.11M 0.39% 32
2020
Q1
$35.9M Sell
144,012
-30,478
-17% -$8.39M 0.36% 42
2019
Q4
$51.3M Buy
174,490
+8,871
+5% +$2.32M 0.39% 39
2019
Q3
$36M Sell
165,619
-1,133
-0.7% -$273K 0.29% 54
2019
Q2
$40.7M Sell
166,752
-6,884
-4% -$1.66M 0.33% 46
2019
Q1
$42.9M Sell
173,636
-21,931
-11% -$5.59M 0.35% 41
2018
Q4
$48.7M Buy
195,567
+3,997
+2% +$1.06M 0.41% 26
2018
Q3
$51M Buy
191,570
+1,266
+0.7% +$329K 0.33% 35
2018
Q2
$46.7M Sell
190,304
-357,565
-65% -$85.9M 0.31% 34
2018
Q1
$117M Sell
547,869
-21,873
-4% -$5M 0.29% 29
2017
Q4
$126M Sell
569,742
-62,062
-10% -$13.2M 0.3% 21
2017
Q3
$124M Sell
631,804
-16,059
-2% -$3.1M 0.29% 22
2017
Q2
$120M Buy
647,863
+426
+0.1% +$74.7K 0.32% 18
2017
Q1
$106M Sell
647,437
-26,412
-4% -$4.33M 0.29% 25
2016
Q4
$108M Buy
673,849
+209,420
+45% +$31.3M 0.31% 23
2016
Q3
$65M Sell
464,429
-107,244
-19% -$15M 0.2% 72
2016
Q2
$80.7M Buy
571,673
+11,179
+2% +$1.49M 0.25% 44
2016
Q1
$72.2M Sell
560,494
-75,093
-12% -$8.88M 0.23% 54
2015
Q4
$74.8M Sell
635,587
-128,005
-17% -$15M 0.22% 65
2015
Q3
$88.6M Sell
763,592
-38,460
-5% -$4.6M 0.27% 29
2015
Q2
$97.8M Buy
802,052
+40,650
+5% +$4.81M 0.24% 36
2015
Q1
$90.1M Sell
761,402
-353,576
-32% -$39.3M 0.21% 58
2014
Q4
$113M Buy
1,114,978
+28,510
+3% +$2.7M 0.28% 25
2014
Q3
$93.7M Buy
1,086,468
+18,357
+2% +$1.55M 0.22% 42
2014
Q2
$87.3M Buy
1,068,111
+324,312
+44% +$25.5M 0.22% 52
2014
Q1
$61M Buy
743,799
+1,111
+0.1% +$83.6K 0.17% 99
2013
Q4
$55.9M Buy
742,688
+128,677
+21% +$9.24M 0.17% 105
2013
Q3
$44M Buy
614,011
+45,756
+8% +$3.27M 0.16% 108
2013
Q2
$37.2M Buy
+568,255
New +$35.4M 0.16% 105

Other funds holding UNH

Guggenheim Capital's UNH Position: Q2 2026 in Review

Guggenheim Capital reduced its UnitedHealth (UNH) stake by 11% in Q2 2026, selling an estimated $2.47M and leaving 54,858 shares worth $22.8M. The position accounts for 0.14% of the portfolio, ranked #132.

Guggenheim Capital first reported a position in UNH in Q2 2013 and has held it in 53 quarters since. The position peaked at $126M in Q4 2017. 3,367 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Guggenheim Capital held 54,858 shares of UnitedHealth worth $22.8M as of Q2 2026.
  • Guggenheim Capital sold 6,656 UnitedHealth shares in Q2 2026, an estimated $2.47M.
  • UnitedHealth made up 0.14% of Guggenheim Capital's portfolio in Q2 2026, its #132 holding.
  • Guggenheim Capital first reported a position in UnitedHealth in Q2 2013 and has held it in 53 quarters since.
  • Guggenheim Capital's UnitedHealth position peaked at $126M in Q4 2017.
  • 3,367 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.